Upgrade to SI Premium - Free Trial

Inovio Pharma (INO)

1.11 +0.01 (0.91%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/12/26)

Latest Headlines

Inovio Pharmaceuticals (INO) PT Lowered to $2.50 at H.C. Wainwright June 1, 2026 6:54 AM - StreetInsider INOVIO to Participate in Upcoming Scientific and Investor Conferences May 28, 2026 8:05 AM - PR NewsWire Form S-8 INOVIO PHARMACEUTICALS, May 26, 2026 6:02 AM - SEC Filing Form 4 INOVIO PHARMACEUTICALS, For: May 20 Filed by: YARNO WENDY L May 21, 2026 4:51 PM - SEC Filing Form 4 INOVIO PHARMACEUTICALS, For: May 20 Filed by: Shepard Jay May 21, 2026 4:32 PM - SEC Filing Form 4 INOVIO PHARMACEUTICALS, For: May 20 Filed by: Miller Ann Calby May 21, 2026 4:12 PM - SEC Filing Form 4 INOVIO PHARMACEUTICALS, For: May 20 Filed by: Weiner David B. May 21, 2026 4:11 PM - SEC Filing Form 4 INOVIO PHARMACEUTICALS, For: May 20 Filed by: Zoth Lota S. May 21, 2026 4:11 PM - SEC Filing Form 4 INOVIO PHARMACEUTICALS, For: May 20 Filed by: DANSEY ROGER D May 21, 2026 4:07 PM - SEC Filing Form 4 INOVIO PHARMACEUTICALS, For: May 20 Filed by: BENITO SIMON X May 21, 2026 4:07 PM - SEC Filing Form 4 INOVIO PHARMACEUTICALS, For: May 20 Filed by: Humeau Laurent May 21, 2026 4:06 PM - SEC Filing Form 4 INOVIO PHARMACEUTICALS, For: May 20 Filed by: Sumner Michael John May 21, 2026 4:06 PM - SEC Filing Form 4 INOVIO PHARMACEUTICALS, For: May 20 Filed by: KIES PETER May 21, 2026 4:05 PM - SEC Filing Form 4 INOVIO PHARMACEUTICALS, For: May 20 Filed by: Shea Jacqueline Elizabeth May 21, 2026 4:05 PM - SEC Filing ApolloBio reports positive phase 3 results for INOVIO's VGX-3100 May 21, 2026 4:05 PM - StreetInsider Positive Topline Results from a Phase 3 Trial for VGX-3100 in Cervical Dysplasia Patients Announced by ApolloBio, INOVIO's Partner in China May 21, 2026 4:05 PM - PR NewsWire Form 8-K INOVIO PHARMACEUTICALS, For: May 19 May 20, 2026 4:02 PM - SEC Filing Form 4 INOVIO PHARMACEUTICALS, For: May 15 Filed by: Shea Jacqueline Elizabeth May 18, 2026 4:11 PM - SEC Filing Form 4 INOVIO PHARMACEUTICALS, For: May 15 Filed by: KIES PETER May 18, 2026 4:09 PM - SEC Filing Form 4 INOVIO PHARMACEUTICALS, For: May 15 Filed by: Humeau Laurent May 18, 2026 4:08 PM - SEC Filing Form 4 INOVIO PHARMACEUTICALS, For: May 15 Filed by: Sumner Michael John May 18, 2026 4:05 PM - SEC Filing Form SCHEDULE 13G/A INOVIO PHARMACEUTICALS, Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC May 15, 2026 6:36 AM - SEC Filing Inovio Pharma (INO) Misses Q1 EPS by 28c May 13, 2026 4:15 PM - StreetInsider Form 8-K INOVIO PHARMACEUTICALS, For: May 13 May 13, 2026 4:08 PM - SEC Filing INOVIO Reports First Quarter 2026 Financial Results and Recent Business Highlights May 13, 2026 4:05 PM - PR NewsWire Form 10-Q INOVIO PHARMACEUTICALS, For: Mar 31 May 13, 2026 4:02 PM - SEC Filing Form SCHEDULE 13G/A INOVIO PHARMACEUTICALS, Filed by: Adage Capital Management, L.P. May 13, 2026 9:07 AM - SEC Filing INOVIO to Participate in Upcoming Scientific Conferences May 8, 2026 8:05 AM - PR NewsWire Form SCHEDULE 13G/A INOVIO PHARMACEUTICALS, Filed by: FMR LLC May 6, 2026 11:24 AM - SEC Filing INOVIO to Report First Quarter Financial Results on May 13, 2026 May 1, 2026 4:05 PM - PR NewsWire Form DEF 14A INOVIO PHARMACEUTICALS, For: May 20 April 7, 2026 4:15 PM - SEC Filing Form 8-K INOVIO PHARMACEUTICALS, For: Apr 02 April 6, 2026 7:03 AM - SEC Filing Form 424B5 INOVIO PHARMACEUTICALS, April 2, 2026 4:57 PM - SEC Filing INOVIO prices $17.5 million public offering at $1.40 per share April 2, 2026 8:55 AM - StreetInsider INOVIO Announces Pricing of $17.5 Million Public Offering April 2, 2026 8:55 AM - PR NewsWire Form 8-K INOVIO PHARMACEUTICALS, For: Apr 01 April 2, 2026 6:15 AM - SEC Filing Form 424B5 INOVIO PHARMACEUTICALS, April 2, 2026 6:06 AM - SEC Filing INOVIO announces proposed public offering of stock and warrants April 1, 2026 8:05 PM - StreetInsider INOVIO Announces Proposed Public Offering April 1, 2026 8:05 PM - PR NewsWire Form 4 INOVIO PHARMACEUTICALS, For: Mar 31 Filed by: Sumner Michael John April 1, 2026 5:05 PM - SEC Filing INOVIO to Participate in Upcoming Scientific Conference April 1, 2026 10:32 AM - PR NewsWire Full Article List